Samy Ammari - Concepedia

Author

Samy Ammari

Also Known As

Ammari Samy, Ammari, Samy, Biomaps, UMR1281 INSERM, CEA, CNRS, Université Paris-Saclay, France, Fatine Selhane, S Ammari, S. Ammari, S. El Ammari, SAMY AMMARI, Samy Ammari, Samy ammari

364

Publications

8.8K

Citations

H-Index

114

Concepts

All Affiliations

Institut Gustave Roussy Inserm Université Paris-Saclay Centre National de la Recherche Scientifique Commissariat à l'Énergie Atomique et aux Énergies Alternatives

About

Samy Ammari is an author at Institut Gustave Roussy specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	41	4.1K
2	Health Sciences	13	13	898
3	Engineering	7	7	442
4	Public Health	1	1	11
5	Social Sciences	1	1	89

Samy Ammari

Publications

7.8K

Citations

H-Index

Page 1

	Year	Citations
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study Roger Sun, Elaine Johanna Limkin, Maria Vakalopoulou, The Lancet Oncology Tumor ImmunologyCancer ImmunosurveillanceOncologic ImagingMedicineImmunology	2018	1.2K
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1 Stéphane Champiat, Laurent Dercle, Samy Ammari, Clinical Cancer Research	2016	1.2K
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial Christophe Massard, Stefan Michiels, Charles Ferté, Cancer Discovery	2017	747
Mechanisms and therapeutic implications of hypermutation in gliomas Mehdi Touat, Yvonne Y. Li, Adam N. Boynton, Nature Neuro-oncologyMedicineTherapeutic ImplicationsHigh-grade GliomasCell Biology	2020	661
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria Mélodie Tazdait, Laura Mezquita, J. Lahmar, European Journal of Cancer OncologyMedicineRecist 1.1Metastatic NsclcImmune Checkpoint Inhibitor	2017	337
Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics Alexandre Carré, G. Klausner, Myriam Edjlali, Scientific Reports	2020	251
Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors Lizza Hendriks, Clémence Henon, Édouard Auclin, Journal of Thoracic Oncology Neuro-oncologyCheckpoint InhibitorsMedicineImmune Checkpoint InhibitorBrain Metastases Treated	2019	238
Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules Fatima‐Zohra Mokrane, Lin Lü, Adrien Vavasseur, European Radiology EngineeringHepatologyMedical ImagingMachine LearningHepatobiliary Tumor	2019	181
Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients Nathalie Lassau, Samy Ammari, Émilie Chouzenoux, Nature Communications	2021	177
Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials Charles Ferté, Marianna Fernandez, Antoine Hollebecque, Clinical Cancer Research	2013	172

Page 1